This document discusses fungal infections in hematology-oncology patients. It covers the epidemiology, diagnosis, and treatment of fungal infections.
This document is a clinical presentation or guide focusing on invasive fungal infections (IFI) in patients with hematological malignancies and oncology. It covers the significance of these infections, including mortality rates and epidemiological data from studies like SEIFEM. The text details specific types of infections such as invasive candidiasis, aspergillosis, and mucormycosis, along with their clinical manifestations in various organs like the skin, lungs, and central nervous system. This manual is written in Turkish.
The mortality rate in adults is between 15% and 35%.
Candidosis is the most common, accounting for 55% of cases.
Prophylaxis is not covered for patients expected to have neutropenia for 10 days or longer.